Filorga
RISINGEarly Signal LiveBeauty & Skincare

Filorga

Filorga eye cream that claims to be 'Botox in a jar' is 2018's most ...

Part of Colgate-Palmolive portfolio →
Market
24Early Stage
Momentum Score
Early Stage
Early1/6

Brand Play: No clear momentum yet. Add this to your watch list and check back in a few days.

+0%7d
🇺🇸US🇲🇽MX🇫🇷FR🇨🇦CA🇬🇧UK
View on Amazon
Momentum Score
-1
/100
Early Stage
50+ trending · 70+ peak momentum
Signal Strength
0/6
Early — platforms active
Window
Monitoring
No momentum window detected yet. Score needs to reach 50+ before a window opens. Watch for a spike in the 7-day trend.
7d Change
+0%
AI Visibility
-4
/100composite
ChatGPT
100
Gemini
100
Perplexity
20
Updated weekly · 50+ visible · 75+ recommended
Early Signal— First mover window is open. Act within 48 hours or set a watch alert.
Social buzz is 24 points ahead of commerce — demand exists but the market hasn't caught up. First mover with strong listings wins this.
Brand Audit Mode
Strategic Moment

This is an early-signal moment for the anti-aging eye cream category, driven by a specific product's 'Botox in a jar' claim. Filorga's social signals, particularly TikTok at 48/100, are significantly ahead of its non-existent commerce signals, with a TikTok Shop Commerce Score of 0/100. Brands that act within the next 60 days to establish a commerce presence will capture market share and define the narrative for this emerging product trend, leaving slower movers to chase.

Why Filorga Is Trending

What's Driving It TikTok (48/100) is the primary driver, with creator content centered on filorga (3.0M plays) and antiaging (1.1M plays) showcasing product application and 'Botox-like' results. Creators are emphasizing the dramatic claims of the eye cream, making it highly share...

Signal Radar

TikTokNews CoverageCreator ReachInstagram

Score Breakdown

0255075100TikTokInstagramNewsCoverageCreatorReach

Compare Brands

Strategic Recommendations

(4 actions)
1

Launch TikTok Shop immediately

Filorga has a TikTok Shop Commerce Score of 0/100 despite strong TikTok content momentum at 48/100, indicating an untapped direct sales channel.

Open a brand-owned TikTok Shop and list the Filorga eye cream within 14 days to capitalize on the 48/100 TikTok momentum before competitors establish a presence. Delaying this will allow competitors to capture the direct purchase intent generated by organic content, forcing Filorga to pay more for customer acquisition later.

2

Brief 10 US micro-creators now

US creators lead at 37% of the total, and TikTok is the highest-scoring platform at 48/100, making creator content a direct path to audience engagement.

Commission 10 US-based micro-creators (50K-200K followers) to create authentic 'Botox in a jar' review content using #filorga and #antiaging, focusing on visible results. This will amplify the existing US creator base (37%) and convert social engagement into direct product consideration.

3

Develop Amazon product page

Amazon shows 0/100, indicating no current presence, which is a major gap for a product with rising search volume and purchase intent.

Create a fully optimized Amazon product listing for the Filorga eye cream with high-quality images, detailed benefits, and A+ content within 30 days. This establishes a critical retail presence where the brand currently has 0/100, preventing competitors from owning the 'Botox in a jar' search terms on Amazon.

4

Expand creator outreach to FR, MX

Creator geography shows significant activity in FR (17%) and MX (20%), indicating ripe markets for targeted expansion beyond the US.

Identify and brief 5-7 micro-creators in France (17% of creators) and Mexico (20% of creators) to localize content around the 'Botox in a jar' claim. This will broaden the product's reach beyond the US, capturing early adoption in key secondary markets before they become saturated.

Action Plan

Filorga's Global Marketing Team — needs to immediately activate direct-to-consumer commerce channels like TikTok Shop and Amazon to monetize the 48/100 TikTok momentum and 22,988/month search volume.
L'Oréal's Skincare Division — could develop a competing 'Botox-effect' eye cream to challenge Filorga's early-mover advantage in this specific claim.
The Ordinary's Product Development Team — should analyze the 'Botox in a jar' claim and consider a high-efficacy, low-cost alternative to capture the younger demographic interested in affordable anti-aging solutions.

Sign in to see the full analysis

Free account — signals, scores & insights unlocked

Create free account

How useful was this?